CDKN2A deletion is associated with immune desertification in diffuse pleural mesothelioma
Abstract Introduction Diffuse Pleural Mesothelioma (DPM) is a rare and incurable cancer. Immune checkpoint inhibitors (ICIs) marked some advances but only for a limited fraction of patients. Improving response prediction to ICIs is currently a clinical need in DPM. Deletion of CDKN2A gene, in chr9p2...
| Published in: | Journal of Experimental & Clinical Cancer Research |
|---|---|
| Main Authors: | Federica Torricelli, Benedetta Donati, Veronica Manicardi, Mila Gugnoni, Francesca Reggiani, Gloria Manzotti, Pierluigi Di Chiaro, Cristian Ascione, Simonetta Piana, Riccardo Valli, Roberto Piro, Massimiliano Paci, Nicola Facciolongo, Filippo Lococo, Alessia Ciarrocchi |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13046-025-03522-4 |
Similar Items
Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapy
by: F Torricelli, et al.
Published: (2023-07-01)
by: F Torricelli, et al.
Published: (2023-07-01)
Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma
by: Miho Yoshida, et al.
Published: (2023-11-01)
by: Miho Yoshida, et al.
Published: (2023-11-01)
CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
by: Eeva Kettunen, et al.
Published: (2019-05-01)
by: Eeva Kettunen, et al.
Published: (2019-05-01)
Pleural mesothelioma metastasis of the scalp
by: Tugcem Bicak, et al.
Published: (2024-02-01)
by: Tugcem Bicak, et al.
Published: (2024-02-01)
CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition
by: Giulia Pinton, et al.
Published: (2021-07-01)
by: Giulia Pinton, et al.
Published: (2021-07-01)
Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition
by: Giulia Pinton, et al.
Published: (2022-11-01)
by: Giulia Pinton, et al.
Published: (2022-11-01)
Prognostic Value of Ki67 Percentage, WT-1 Expression and p16/CDKN2A Deletion in Diffuse Malignant Peritoneal Mesothelioma: A Single-Centre Cohort Study
by: Federica Pezzuto, et al.
Published: (2020-06-01)
by: Federica Pezzuto, et al.
Published: (2020-06-01)
Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma
by: Sophie Sneddon, et al.
Published: (2017-06-01)
by: Sophie Sneddon, et al.
Published: (2017-06-01)
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
by: E. Genescà, et al.
Published: (2018-07-01)
by: E. Genescà, et al.
Published: (2018-07-01)
Genetic study of the CDKN2A and CDKN2B genes in renal cell carcinoma patients
by: Nattaradee Kiatprungvech, et al.
Published: (2024-05-01)
by: Nattaradee Kiatprungvech, et al.
Published: (2024-05-01)
Diagnosis and management of pleural mesothelioma: three unique cases and review of the literature
by: Zeina Al Achkar, et al.
Published: (2026-04-01)
by: Zeina Al Achkar, et al.
Published: (2026-04-01)
Exploring the transcriptional cooperation between RUNX2 and its associated elncRNA RAIN
by: Emanuele Vitale, et al.
Published: (2024-09-01)
by: Emanuele Vitale, et al.
Published: (2024-09-01)
Ex vivo mapping of enhancer networks that define the transcriptional program driving melanoma metastasis
by: Veronica Manicardi, et al.
Published: (2023-12-01)
by: Veronica Manicardi, et al.
Published: (2023-12-01)
OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer
by: Mila Gugnoni, et al.
Published: (2022-03-01)
by: Mila Gugnoni, et al.
Published: (2022-03-01)
The phenogenomic landscapes of pleural mesothelioma tumor microenvironment predict clinical outcomes
by: Federica Torricelli, et al.
Published: (2025-02-01)
by: Federica Torricelli, et al.
Published: (2025-02-01)
Unusual Histology in Mesothelioma: A Report of Two Cases with a Brief Review
by: Francesca Bono, et al.
Published: (2022-02-01)
by: Francesca Bono, et al.
Published: (2022-02-01)
Pleural mesothelioma: When echo‐endoscopy (EUS‐B‐FNA) leads to diagnosis in a minimally invasive way
by: Roberto Piro, et al.
Published: (2021-03-01)
by: Roberto Piro, et al.
Published: (2021-03-01)
Pleural Mesothelioma: Unexpected Finding in a Young Man
by: Raza Ullah, et al.
Published: (2022-07-01)
by: Raza Ullah, et al.
Published: (2022-07-01)
Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
by: Jacopo Moro, et al.
Published: (2022-12-01)
by: Jacopo Moro, et al.
Published: (2022-12-01)
Deoxyribonucleic acid methylation in the enhancer region of the CDKN2A/2B and CDKN2B-AS1 genes in blood vessels and cells in patients with carotid atherosclerosis
by: Yu. A. Koroleva, et al.
Published: (2020-11-01)
by: Yu. A. Koroleva, et al.
Published: (2020-11-01)
Polymorphism rs2383207 of CDKN2B-AS and Susceptibility to Atherosclerosis: A Mini Review
by: Sofia Vladimorovna Timofeeva, et al.
Published: (2022-11-01)
by: Sofia Vladimorovna Timofeeva, et al.
Published: (2022-11-01)
ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease
by: Yahui Kong, et al.
Published: (2018-07-01)
by: Yahui Kong, et al.
Published: (2018-07-01)
Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations
by: Anita Sejben, et al.
Published: (2023-04-01)
by: Anita Sejben, et al.
Published: (2023-04-01)
The role of CD24 as a potential biomarker for malignant pleural mesothelioma
by: Mohamed Shaaban Mousa, et al.
Published: (2023-01-01)
by: Mohamed Shaaban Mousa, et al.
Published: (2023-01-01)
Malignant Mesothelioma in Cappadocia: Data from Eight Regional Hospitals
by: İpek Pınar Aral, et al.
Published: (2020-09-01)
by: İpek Pınar Aral, et al.
Published: (2020-09-01)
Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy
by: Margaret Stalker, MD, et al.
Published: (2025-05-01)
by: Margaret Stalker, MD, et al.
Published: (2025-05-01)
Investigational approaches for mesothelioma
by: Veerle F Surmont, et al.
Published: (2011-08-01)
by: Veerle F Surmont, et al.
Published: (2011-08-01)
Malignant pleural mesothelioma
by: Rao Sukhesh
Published: (2009-01-01)
by: Rao Sukhesh
Published: (2009-01-01)
Malignant pleural mesothelioma in a child
by: Jed Brendan Scharf, et al.
Published: (2015-10-01)
by: Jed Brendan Scharf, et al.
Published: (2015-10-01)
Malignant mediastinal mesothelioma treated with anlotinib: a case report and review of the literature
by: Yishi Zhang, et al.
Published: (2023-05-01)
by: Yishi Zhang, et al.
Published: (2023-05-01)
CT imaging of malignant peritoneal mesothelioma: A case report
by: Agnes Triana Basja, MD, et al.
Published: (2022-04-01)
by: Agnes Triana Basja, MD, et al.
Published: (2022-04-01)
Miliary Mesothelioma
by: Dujinthan Jayabalan, et al.
Published: (2025-03-01)
by: Dujinthan Jayabalan, et al.
Published: (2025-03-01)
Recurrent malignant peritoneal mesothelioma treated by a second resection: A case report
by: Takashi Miyata, et al.
Published: (2023-05-01)
by: Takashi Miyata, et al.
Published: (2023-05-01)
A meta-analysis of the prognostic significance of CDKN deletions in acute lymphoblastic leukaemia
by: Xiaoshan Hu, et al.
Published: (2024-12-01)
by: Xiaoshan Hu, et al.
Published: (2024-12-01)
New Insights in Pleural Mesothelioma Classification Update: Diagnostic Traps and Prognostic Implications
by: Maria Giovanna Mastromarino, et al.
Published: (2022-11-01)
by: Maria Giovanna Mastromarino, et al.
Published: (2022-11-01)
Gluteal muscle metastases from malignant pleural mesothelioma: a case report
by: Emanuele Stirpe, et al.
Published: (2024-05-01)
by: Emanuele Stirpe, et al.
Published: (2024-05-01)
Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis
by: Nanamika Thakur, et al.
Published: (2021-01-01)
by: Nanamika Thakur, et al.
Published: (2021-01-01)
Mesothelioma - a growing medical problem with heterogeneous course
by: Robert Chudzik, et al.
Published: (2019-02-01)
by: Robert Chudzik, et al.
Published: (2019-02-01)
MONITORING OF MESOTHELIOMA IN SOUTHERN BRAZIL: A SITUATION TO BE INVESTIGATED
by: Francisco José Koller, et al.
Published: (2017-03-01)
by: Francisco José Koller, et al.
Published: (2017-03-01)
Mesothelium and Malignant Mesothelioma
by: Emilye Hiriart, et al.
Published: (2019-04-01)
by: Emilye Hiriart, et al.
Published: (2019-04-01)
Similar Items
-
Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapy
by: F Torricelli, et al.
Published: (2023-07-01) -
Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma
by: Miho Yoshida, et al.
Published: (2023-11-01) -
CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
by: Eeva Kettunen, et al.
Published: (2019-05-01) -
Pleural mesothelioma metastasis of the scalp
by: Tugcem Bicak, et al.
Published: (2024-02-01) -
CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition
by: Giulia Pinton, et al.
Published: (2021-07-01)
